Skip to main content
. 2013 Jul 1;13:301. doi: 10.1186/1471-2334-13-301

Table 1.

Characteristics of patients in TDF+PI/r and control groupsa

Variable TDF+PI/r group (n=75) Control group (n=75) P
Male
58(77.3)
53(70.7)
0.352
Age (years)
44 (41–50)
42 (34–53)
0.322
Race
 
 
0.363
  Han
74 (98.7)
71 (94.7)
 
  Other
1 (1.3)
4 (5.3)
 
Duration of HIV seropositive (months)
65 (26–139)
22 (19–28)
<0.001
Smoking
 
 
 
  Yes
32(42.7)
27(36.0)
0.403
  No
43(57.3)
48(64.0)
 
Hypertension
 
 
0.347
  Yes
7(9.3)
4(5.3)
 
  No
68(90.7)
71(94.7)
 
Diabetes
 
 
0.332
  Yes
4(5.3)
1(1.3)
 
  No
67(89.3)
68(90.7)
 
  Unknown
4(5.3)
6(8.0)
 
BMIb(kg/m2)
21.6 (20.1-23.5)
20.6 (19.5-23.0)
0.129
CD4 cell count (cells/μl)
157(63–267)
185 (104–259)
0.509
Viral load (log10 copies/ml)
4.4 (3.7-4.8)
4.5 (3.9-4.9)
0.117
Proteinuria
 
 
0.631
  Positive
11(14.7)
9 (12)
 
  Negative
64(85.3)
66 (88)
 
Serum creatinine (μmol/L)
71(65–81)
71.4(62–81.7)
0.263
eGFRc(ml/min/1.73 m2) 101.6 (85.6-117.2) 105.1 (76.8-110.3) 0.376

Note.

aValues are expressed as median (interquartile range) or number (percentage).

bBMI =weight (kg)/(height (m))2.

ceGFR = 186 × (Serum creatinine (mg/dL))-1.154 × (age(years))-0.203 × (0.742 if female).